AdAlta Limited chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 0.02
Dividend & YieldN/A$ (N/A)
Beta 0.76
Market capitalization 15.71M
Operating cash flow -4.82M
ESG Scores unknown

Company description

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is based in Bundoora, Australia.

Sector: Healthcare - Industry: Biotechnology

Financial data

Financial Statements

Cashflow Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Change To Liabilities -766 1.45M -910.25k 21.21k
Total Cashflows From Investing Activities -3.14k -170.6k -2.38k -2.12k
Net Borrowings 2.08M 2.08M 2.08M -601.47k
Total Cash From Financing Activities 13.19k 9.24M 3.7M 7.19M
Change To Operating Activities 22.57k -2.37k 30.07k -74.39k
Issuance Of Stock 13.19k 9.95M 1.78M 8.12M
Net Income -3.85M -5.92M -6.01M -5.63M
Change In Cash -3.92M 3.25M -2.19M 2.42M
Effect Of Exchange Rate 14.67k 14.67k 14.67k 14.67k
Total Cash From Operating Activities -3.93M -5.82M -5.89M -4.78M
Depreciation 3.14k 32.5k 41.83k 29.08k
Change To Account Receivables -267.63k -1.48M 249.05k 256.01k
Other Cashflows From Financing Activities -716.09k -716.09k -153.19k -327.47k
Change To Netincome 168.96k 100.7k 706k 614.7k
Capital Expenditures -3.14k -170.6k -2.38k -2.12k

Income Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Research Development 7.01M 7.01M 7.01M 6.23M
Income Before Tax -3.85M -5.92M -6.01M -5.63M
Net Income -3.85M -5.92M -6.01M -5.63M
Selling General Administrative 1.02M 1.13M 1.85M 2.42M
Gross Profit -2.13M -4M 3.66M 3.78M
Ebit -3.86M -5.99M -5.84M -5.42M
Operating Income -3.86M -5.99M -5.84M -5.42M
Interest Expense -115.55k -115.55k -115.55k -97.64k
Income Tax Expense
Total Revenue 2.02M 3.54M 3.83M 3.98M
Cost Of Revenue 4.15M 7.54M 170.29k 201.22k
Total Other Income ExpenseNet 7.05k 70.89k -166.6k -210.06k
Net Income From Continuing Ops -3.85M -5.92M -6.01M -5.63M
Net Income Applicable To Common Shares -3.85M -5.92M -6.01M -5.63M

Balance Sheet Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Total Liabilities 366.32k 1.82M 3.21M 2.66M
Total Stockholder Equity 4.07M 7.49M 3.7M 6.39M
Other Current Liabilities 40.61k 18.8k 174.72k 70.37k
Total Assets 4.44M 9.31M 6.91M 9.05M
Common Stock 17.57M 26.53M 28.44M 36.23M
Other Current Assets 77.92k
Retained Earnings -13.67M -19.59M -25.6M -31.23M
Treasury Stock 172.87k 553.83k 864.02k 1.38M
Cash 2.31M 5.56M 3.37M 5.79M
Total Current Liabilities 366.32k 1.82M 3.21M 2.66M
Other Stockholder Equity 172.87k 553.83k 864.02k 1.38M
Property, Plant, and Equipment 138.1k 98.65k 71.69k
Total Current Assets 4.44M 9.17M 6.73M 8.98M
Net Tangible Assets 4.07M 7.49M 3.7M 6.39M
Net Receivables 2.08M 3.58M 3.31M 2.98M
Accounts Payable 74.59k 1.51M 540.83k 215.72k


Insider Transactions

Here are the insider transactions of stock shares related to AdAlta Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Williams (James)Other at price 0.05 per share.D2022-02-07Alternate Director10.42k
Oldham (Timothy Charles)Other at price 0.05 per share.D2022-02-07Chief Executive Officer55.75k
Fuller (David)Other at price 0.05 per share.D2022-02-07Director (Non-Executive)23.41k
Peach (Robert James)Other at price 0.05 per share.D2022-02-07Director (Non-Executive)157.13k
Oldham (Timothy Charles)Purchase at price 0.07 per share.D2021-10-26Chief Executive Officer235k
Oldham (Timothy Charles)Purchase at price 0.09 per share.D2020-11-26Chief Executive Officer61k
McCall (Elizabeth)Other at price 0.07 per share.D2020-09-08Director (Non-Executive)33.33k
Williams (James)Other at price 0.07 per share.D2020-09-08Alternate Director43.33k
Oldham (Timothy Charles)Other at price 0.07 per share.D2020-09-08Chief Executive Officer30k
Fuller (David)Other at price 0.07 per share.D2020-09-08Director (Non-Executive)37.45k
Oldham (Timothy Charles)Purchase at price 0.06 per share.D2020-03-06Chief Executive Officer120k
Peach (Robert James)Other at price 0.11 per share.D2019-07-03Director (Non-Executive)962.67k
McCall (Elizabeth)Other at price 0.11 per share.D2019-07-03Director (Non-Executive)33.33k
MacLeman (Paul)Other at price 0.11 per share.D2019-07-03Chairman of the Board33.33k
Williams (James)Other at price 0.11 per share.D2019-07-03Director (Non-Executive)133.33k
Peach (Robert James)Other at price 0.22 per share.D2018-11-28Director333.33k
Chiplin (John C)Other at price 0.22 per share.D2018-11-28Director (Independent)189.12k
Cobb (Samantha)D2017-11-30Chief Executive Officer356.39k
MacLeman (Paul)Exercise at price 0.07 per share.D2017-09-25Chairman of the Board146.54k
MacLeman (Paul)Exercise at price 0.00 per share.D2016-12-21Chairman of the Board73.27k
Chiplin (John C)Exercise at price 0.07 per share.D2016-11-07Director (Independent)43.96k
Chiplin (John C)Exercise at price 0.00 per share.D2016-11-07Director (Independent)43.96k
Chiplin (John C)Exercise at price 0.07 per share.D2016-10-21Director (Independent)117.24k
Chiplin (John C)Exercise at price 0.00 per share.D2016-10-21Director (Independent)43.96k
Cobb (Samantha)D2016-09-27Chief Executive Officer434.36k
MacLeman (Paul)Exercise at price 0.00 per share.D2016-09-27Chairman of the Board73.27k
MacLeman (Paul)Exercise at price 0.07 per share.D2016-09-27Chairman of the Board73.27k
Williams (James)Purchase at price 0.18 per share.D2016-09-21Director (Non-Executive)40k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to AdAlta Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on AdAlta Limited

Here is the result of two systematic investment strategies applied to AdAlta Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on AdAlta Limited

The following chart shows the equity curve of the two systematic investment strategies applied to AdAlta Limited:

AdAlta Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -3.18% on the backtest period.

Performance at glance

Performance

-3.18 %

Latent gain

-55.62 $

Invested capital

1750.02 $

Annualized return

-0.75 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on AdAlta Limited

This is the result of two momentum investment strategies applied to AdAlta Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on AdAlta Limited

The following chart shows all the entries opened by the momentum investment system on AdAlta Limited:

AdAlta Limited momentum entries
  • The first momentum investment strategy would give -1.4% of return on AdAlta Limited. That represents -94.73$ of latent gain with 6750.09$ of employed capital.
  • The second momentum investment strategy would give 10.39% of return on AdAlta Limited. That represents 493.54$ of latent gain with 4750.14$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-1.4 %

Latent gain

-94.73 $

Invested capital

6750.09 $

Annualized return

100.18 %
Performance at glance (2Q Momentum)

Performance

10.39 %

Latent gain

493.54 $

Invested capital

4750.14 $

Annualized return

2.75 %

Momentum equity curve on AdAlta Limited

The following chart shows the equity curve of the two momentum strategies applied to AdAlta Limited:

AdAlta Limited momentum equity

Note: the dividends potentially given by AdAlta Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on AdAlta Limited

The following chart shows the employed capital evolution of the two momentum strategies on AdAlta Limited since the beginning:

AdAlta Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on AdAlta Limited

Buy the dip entry openings on AdAlta Limited

AdAlta Limited

The performance achieved by the robo-advisor on AdAlta Limited is 226.4%. That represents 1132.0$ of latent gain with 500.0$ of employed capital. The following chart shows AdAlta Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of AdAlta Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

226.4 %

Latent gain

1132.0 $

Invested capital

500.0 $

Annualized return

100.18 %

Equity curve of the strategy applied to AdAlta Limited

The following chart shows the result of the investment strategy applied to AdAlta Limited:

AdAlta Limited

Note: the dividends potentially given by AdAlta Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on AdAlta Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on AdAlta Limited:

AdAlta Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on AdAlta Limited

In this section, I will compare the three previous investment strategies applied to AdAlta Limited.

Equity curve comparison on AdAlta Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

AdAlta Limited investment strategy comparison

Employed capital comparison on AdAlta Limited

AdAlta Limited investment comparison

Performance comparison on AdAlta Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -3.18% -55.62$ 1750.02$ -0.75%
Momentum 1 quarter -1.4% -94.73$ 6750.09$ -0.35%
Momentum 2 quarters 10.39% 493.54$ 4750.14$ 2.75%
Non-directional 226.4% 1132.0$ 500.0$ 100.18%
Annualized return comparison

Automatic investment

-0.75 %

Momentum 1Q

2.75 %

Momentum 2Q

2.75 %

Non-directional

100.18 %

Correlated stocks

Here are the most positively and negatively correlated stocks with AdAlta Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between AdAlta Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of AdAlta Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name AdAlta Limited
Country Australia
City Bundoora
Address 2 Park Drive
Phone 61 3 9479 5159
Website www.adalta.com.au
FullTime employees
Industry Biotechnology
Sector Healthcare
Exchange XASX
Ticker 1AD.XASX
Market www2.asx.com.au

AdAlta Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown